Rosadini G, Marenco S, Nobili F, et al
0.96), and a 19% reduction in the risk of all cause death compared to placebo (HR: 0.81
I would be interested to see further research in this area. With acknowledged benefits for people with diabetes, having first been approved for use in 2005, GLP-1 drugs for weight loss may re-position overweight and obesity in a clearly medical context, with the potential of reducing the historical stigma associated with these conditions
However, people prone to yeast infections generally have multiple factors at play
Journal of Regenerative Medicine, 15 (4), 345-359
Antioxidants counteract free radicals because theyre essentially self-sacrificing soldiers. As Byrnes explained, they donate an electron to free radicals to calm them down and are consumed in the process